About the Journal

Quantitative Imaging in Medicine and Surgery

Aims and Scope

Quantitative Imaging in Medicine and Surgery (QIMS, Quant Imaging Med Surg, Print ISSN 2223-4292; Online ISSN 2223-4306) publishes peer-reviewed original reports and reviews in medical imaging, including X-ray, ultrasound, computed tomography, magnetic resonance imaging and spectroscopy, nuclear medicine and related modalities, and their application in medicine and surgery. While focus is on clinical investigations, papers on medical physics, image processing, or biological studies which have apparent clinical relevance are also published. This journal encourages authors to look at the medical images from a quantitative angle. This journal also publishes important topics on imaging-based epidemiology, and debates on research methodology, medical ethics, and medical training. Descriptive radiological studies of high clinical importance are published as well.

QIMS is an open-access, international peer-reviewed journal, published by AME Publishing Company. It is published quarterly (Dec. 2011- Dec. 2012), bimonthly (Feb. 2013 - Feb 2018), monthly (Mar. 2018 - ) and openly distributed worldwide.

QIMS is indexed in PubMed/PubMed Central, Scopus, Web of Science [Science Citation Index Expanded (SCIE)]. The latest impact factor is: 2.9.

Indexing

Quantitative Imaging in Medicine and Surgery is indexed and covered by

Information for Authors

QIMS is a member of Committee on Publication Ethics (COPE) and it follows the Committee on Publication Ethics (COPE)'s guidelines and the ICMJE recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journal.

Manuscripts submitted must be the original work of the author(s) and must not be published previously or under consideration for publication elsewhere.

Manuscripts Turnaround Time

  • First Editorial Decision: 3-5 days
  • Peer review: 1-2 months
  • Revision time: 2-4 weeks
  • Publication Ahead of Print: within 1 month after being accepted
  • Formal publication: within 1-3 months after being accepted. Original Articles are listed as priority.

QIMS’s position on case reports and review articles.

QIMS welcomes case reports where quantitative imaging played a role for diagnosis and/or treatment; also welcome first time realization (in animals or in human subjects) of a new imaging technique. These case reports are usually written a concise and short letter format (see <https://qims.amegroups.com/>) for example. Case reports of particular clinical importance are also published in a longer format; for these cases we expect important pathophysiological, diagnostic, therapeutic implications. We do not publish case report only because of the rarity of the cases. Note, although we believer reporting case materials is important for the advancement of medicine. The space reserved for case report remains limited for each issue. The decision to publish or not publish a case material submission can sometimes depend on the available space of the journal.

QIMS welcomes reviews and comments on published papers. Review papers should contain authors’ analytical appraisal of published papers and personal viewpoints, instead of a mere aggregation of published abstracts.

We expect review papers are in three forms, 1) expert reviews, usually published in editorial format, provide authors’ own insights and perspective; 2) systematic review; 3) educational reviews, including pictorial reviews. Systematic reviews (maybe narrative in writing but critical in nature) are particularly welcomed.

Publication Schedule

Published quarterly from Dec. 2011 to Dec. 2012 and bimonthly from Feb. 2013 to Feb 2018, QIMS now follows a monthly publication model.

Open Access Statement

This journal is a peer reviewed, open access journal. All content of the journal is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). All articles published open access will be immediately and permanently free for all to read, download, copy and distribute as defined by the applied license.

Free access and usage
Permitted third party reuse is defined by the CC BY-NC-ND 4.0 license. This license allows users to copy and distribute the article, provided:

  • this is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way.
  • the user gives appropriate credit (with a link to the formal publication through the relevant DOI) and provides a link to the license but not in an any way implying that the licensor is endorsing the user or the use of the work.
  • no derivatives including remix, transform, or build upon the material was allowed for distribution.

The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/

Copyright

For open access publishing, this journal uses an exclusive licensing agreement. Authors will transfer copyright to AME Publishing Company, but will have the right to share their article in the same way permitted to third parties under the relevant user license, as well as certain scholarly usage rights.

For any inquiry/special circumstance on the copyright, commercial usage or adaptation of QIMS articles, please contact: permissions@amegroups.com

For reprint order, please contact: sales@amegroups.com

Support for Authors to Comply with Funding Body Mandates

We work with authors of research articles supported by funding bodies with open access mandates to ensure that authors can meet their funders’ requirements for public access to research results.

In addition, we offer further support for authors who are required to comply with funding body mandates, including but not limited to:

Editorial Office

Email: qims@amepc.org

Publisher Information

QIMS is published by AME Publishing Company.
Addresses:
Hong Kong branch office: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.
Singapore branch office: Pico Creative Centre, 20 Kallang Ave #03-08, 339411 Singapore, Singapore.

 

Updated on July 19, 2024